New Delhi: GlobalData’s report, “Electrophysiology Diagnostic Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033,” reveals that the US EP catheter market growth is driven by increasing physician adoption, improved reimbursement policies, rising patient awareness, and the launch of next-generation device innovations, highlighting the evolving landscape of cardiac care solutions.
Electrophysiology diagnostic catheters are used to detect and manage arrhythmias, irregular heart rhythms commonly associated with an ageing population and lifestyle factors such as hypertension, obesity, and physical inactivity.
Thomas Fleming, Medical Analyst at GlobalData, comments: “Market drivers include the growing incidence of arrhythmias, increasing adoption of minimally invasive procedures, and the high effectiveness of EP diagnostic and ablation techniques. ”
Despite the promising growth trajectory, the market faces notable challenges. The high cost of advanced EP diagnostic catheters could hinder accessibility, particularly in cost-sensitive healthcare settings.
Additionally, the growing adoption of reprocessed catheters—priced at nearly 50 per cent less than new devices—creates a significant competitive hurdle for manufacturers. With reprocessing permitted in certain markets, it continues to impact potential revenue streams for original equipment manufacturers.
